Printer Friendly
Email to a Friend
Enlarge Font
Decrease Font
, Staff Writer
Comment on this story
CHAPEL HILL -
Rho, a drug research company, received a $38.9 million contract from the National Institutes of Health.Under the contract, Rho will provide biostatistical, data management and safety services to the Immune Tolerance Network, a group of researchers based at the University of California at San Francisco, and the Asthma Diseases Cooperative Research Centers.The two organizations focus on immunology and asthma research, areas in which Triangle drug researchers have a lot of expertise, said Ronald Helms, chief scientific officer at Rho, which is based in Chapel Hill.Herman E. Mitchell, a Rho executive, will oversee the contract work. Mitchell has worked with the National Cancer Institute to establish operations in Belarus and Ukraine and study the effects of the nuclear disaster in Chernobyl.Rho was founded in 1984 by two UNC-Chapel Hill researchers. The company now employs about 350, mostly in Chapel Hill.
All rights reserved. This copyrighted material may not be published, broadcast or redistributed in any manner.
Get $150+ in coupons in every Sunday N&O. Click here for convenient home delivery.
Staff writer Sabine Vollmer; Staff writer John Murawski
